Subex wins multi-million dollar deal from Middle Eastern mobile operator

This is the sixth multiple ROC solution win for Subex in the Middle East

Subex Ltd has been selected to provide its industry leading revenue operations centre (ROC) fraud management and revenue assurance solutions to the leading Middle Eastern mobile operator.

This is the sixth multiple ROC solution win for Subex in the Middle East. The wide range of Subex references in the region as well as Subex's expertise in the fraud management and revenue assurance domain, helped secure the contract.

ROC Fraud Management is Subex's award-winning solution that helps wireless and wireline operators eliminate known frauds, uncover new fraud patterns, minimise fraud run time, augment internal controls and support continuous fraud management process improvement.

ROC revenue assurance is designed not only to detect potential revenue loss, but also to assist an operator with its investigation, diagnosis and recovery of these revenues. It provides unprecedented automated correction capabilities to improve bottom-line results and provide a quick return-on-investment.
In the late afternoon, Subex was trading at around Rs28 per share on the Bombay Stock Exchange, 2.69% down from the previous close.

User

Ranbaxy launches Atorvastatin in Germany

On 30th November, Ranbaxy had launched Atorvastatin, a generic version of Lipitor in the US market

Gurgaon-based Ranbaxy Laboratories Ltd has launched Atorvastatin Basics, a generic version of the cholesterol lowering drug Sortis in the German market.
Atorvastatin Basics is launched in the strength of 10mg, 20mg, 40mg and 80mg.

Ranbaxy had obtained, pursuant to a settlement agreement with Pfizer, the rights to an early entry of Atorvastatin in the German market. Pfizer's patent for Sortis expires in Germany on 7th May. Daiichi Sankyo Deutschland GmbH will assist in the launch of Atorvastatin Basics. Daiichi Sankyo has a substantial reach amongst cardiologists and physicians in the German market.

Apart from Germany, Daiichi Sankyo and Ranbaxy are working on synergies in other countries, such as India, Romania, Italy and Mexico, among others.
Earlier on 30th November, Ranbaxy had launched Atorvastatin, a generic version of Lipitor in the US market with 180 days of marketing exclusivity, as it was a first-to-file (FTF) applicant on the product. Recently, Ranbaxy also introduced generic Atorvastatin in Australia with three months exclusivity.

In the late afternoon, Ranbaxy was trading at around Rs411 per share on the Bombay Stock Exchange, 1.57% down from the previous close.

User

Axis Bank, NIIT IFBI launch diploma program in retail banking

The program aims to build a pool of modern banking professionals for Axis Bank

Axis Bank and NIIT Institute of Finance, Banking & Insurance Training Ltd (IFBI) has launched post graduate diploma in retail banking (PGDRB), a career program designed for Axis Bank. The program aims to build a pool of modern banking professionals for Axis Bank. To this end, IFBI has designed a comprehensive program that builds competencies on 4 dimensions—domain, application, technology and customer-service needed by banking professionals.

Admission to the PGDRB Program will be through admission test and interview. The selected candidates will be provided with provisional appointment letters at the time of enrolment, and after successful completion of the program will join Axis Bank at the officer level.

After completion of the program students will join Axis Bank as front desk officers who are the first point of contact for customers.

In the late afternoon, Axis Bank was trading at around Rs1,160 per share on the Bombay Stock Exchange, 0.9% up from the previous close.

User

COMMENTS

RAMARAJU NAGESHWARRAO

5 years ago

iwish tojoin

aasawari valse

5 years ago

Plz send the details.... i want to take the addmision & complete the course

Ankita Kadam

5 years ago

I want to join course pls send me details

Bibek Bhattacharjee

5 years ago

I want to join the course. Pl send me the details.

RICHA SHARMA

5 years ago

I want to join the course. Pl send me the details.

subrata ghosh

5 years ago

i want to join this pd diploma course.my mobail number 8609099881

SAURABBH SAXENA

5 years ago

hi i want to join this pd diploma programme but rightnow i am pursuing mba from smu. so plz give me suggestion is this suitable for me. plz call on 8459084565

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)